SCHEMBL9901006

SCHEMBL9901006

Cc1cc(O)c(CC=O)c(O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.47
BACE1 P56817 1/20 0.47
SELL P14151 1/20 0.44
SELP P16109 1/20 0.44
SELE P16581 1/20 0.44
ACHE P22303 1/20 0.44
ERN1 O75460 2/20 0.41
TRPA1 O75762 1/20 0.36
PIM1 P11309 2/20 0.35
ALDH1A1 P00352 4/20 0.35
DAO P14920 1/20 0.34
CYP19A1 P11511 1/20 0.34
MAOB P27338 4/20 0.34
MAPK1 P28482 3/20 0.33
POLB P06746 2/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 2/20 0.33
APEX1 P27695 2/20 0.33
KMT2A Q03164 2/20 0.33
NPC1 O15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6262244 0.90 PTPN1 (0.40) PTPN1BACE1SELLSELPSELE
SCHEMBL742431 0.81 SLC28A3 (0.38) BACE1ALDH1A1CYP19A1MAOBKMT2A
Water SCHEMBL6998437 0.79 SLC28A3 (0.36) BACE1ALDH1A1CYP19A1MAOBKMT2A
SCHEMBL16099420 0.77 ERN1 (0.38) BACE1ERN1MAOBMAOAPPARG
SCHEMBL29115719 0.77 PTPN1 (0.47) PTPN1BACE1SELLSELPSELE
SCHEMBL1124861 0.76 HRH3 (0.36) ERN1ALDH1A1MAPTKMT2AKDM4E
SCHEMBL9788451 0.76 PTPN1 (0.69) PTPN1BACE1TRPA1CYP19A1MAOB
SCHEMBL9901526 0.74 PTPN1 (0.45) PTPN1BACE1SELLSELPSELE
SCHEMBL28418499 0.73 ERN1 (0.46) SELLSELPSELEACHEERN1
SCHEMBL2470125 0.73 CYP3A4 (0.41) ACHEERN1ALDH1A1MAOBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4419532-A1 FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS F. Hoffmann-La Roche AG (CH) 2024-08-28 EP disclosed
WO-2023066825-A1 FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2023-04-27 WO disclosed
EP-2984077-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING SWEET TASTE Chromocell Corporation (US) 2016-02-17 EP disclosed
WO-2014153000-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING SWEET TASTE CHROMOCELL CORPORATION (US) 2014-09-25 WO disclosed
EP-2649066-A1 HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS Autifony Therapeutics Limited (GB) 2013-10-16 EP disclosed
WO-2012076877-A1 HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS AUTIFONY THERAPEUTICS LIMITED (GB) 2012-06-14 WO disclosed
EP-0104018-A2 Benzopyran, benzothiapyran and quinoline compounds and pharmaceutical compositions containing them FISONS plc (GB) 1984-03-28 EP disclosed